AG
VCNX

Advisor Group’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Advisor Group’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4K Hold
4
– – ﹤0.01% 4791
2019
Q3 		$6K Hold
4
– – ﹤0.01% 4604
2019
Q2 		$4K Hold
4
– – ﹤0.01% 4796
2019
Q1 		$4K Hold
4
– – ﹤0.01% 4795
2018
Q4 		$3K Hold
4
– – ﹤0.01% 4745
2018
Q3 		$6K Buy
+4
New +$8.26K ﹤0.01% 4537

Other funds holding VCNX

MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisor Group's VCNX Position: Q4 2019 in Review

Advisor Group held its Vaccinex, Inc. Common Stock (VCNX) position steady in Q4 2019 at 4 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4791.

Advisor Group first reported a position in VCNX in Q3 2018 and has held it in 6 quarters since. The position peaked at $6K in Q3 2019. 11 funds tracked by Wall St. Rank hold VCNX as of Q4 2019.

  • Advisor Group held 4 shares of Vaccinex, Inc. Common Stock worth $4K as of Q4 2019.
  • Advisor Group left its Vaccinex, Inc. Common Stock share count unchanged in Q4 2019.
  • Vaccinex, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4791 holding.
  • Advisor Group first reported a position in Vaccinex, Inc. Common Stock in Q3 2018 and has held it in 6 quarters since.
  • Advisor Group's Vaccinex, Inc. Common Stock position peaked at $6K in Q3 2019.
  • 11 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.